Societal Perspectives' Analysis for Evaluating Direct-Acting Antivirals Affordability While Awaiting Liver Transplant

Hepatology - United States
doi 10.1002/hep.29558
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Direct Acting Antivirals for Decompensated Cirrhosis. Efficacy and Safety Are Now Established

Journal of Hepatology
Hepatology
2016English

Hepatocellular Carcinoma and Direct-Acting Antivirals: A Never Ending Story?

Liver International
Hepatology
2017English

Direct-Acting Antivirals for the Treatment of Hepatitis C Virus Infection: Optimizing Current IFN-free Treatment and Future Perspectives

Liver International
Hepatology
2016English

Indirect and Direct Standardization for Evaluating Transplant Centers

Journal of Hospital Administration
2018English

De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era

Hepatology
MedicineHepatology
2018English

Letter: HBV/HCV Coinfection in the Era of Direct-Acting Antivirals

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy